FGF Therapeutics INC.

Zionsville, IN · Biotech · Private

Humanized FGF23-Fc fusion protein therapeutic for hyperphosphatemic familial tumoral calcinosis

Grants
$302K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Novel Therapy for Hyperphosphatemic Familial Tumoral Calcinosis (hfTC) and Generalized Hyperphosphatemia$301,892
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1115Mu Therapeutics Inc.——
1116OPERATIONAL TECHNOLOGIES CORPORATION——
1117NUTRASORB LLC——
1118FGF Therapeutics INC.——
1119DURAVAX INC——
1120XGENOMES CORP.——
1121LYTICON, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.